Comprehensive validation of early diagnostic algorithms for myocardial infarction in the emergency department

M Tada1,2,3, H Matano4, H Azuma5

  • 1Department of Emergency Medicine, Nagoya City University East Medical Center, Aichi, Japan.

Insights

High-sensitivity cardiac troponin I (hs-cTnI) assays improve early myocardial infarction diagnosis. The High-STEACS pathway using hs-cTnI offers excellent safety and efficiency for identifying low-risk patients.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Biomarker Assays

Background:

  • Myocardial infarction diagnosis relies on timely and accurate risk stratification.
  • High-sensitivity cardiac troponin I (hs-cTnI) assays have emerged as crucial tools in emergency departments.
  • Evaluating diagnostic algorithms is essential for optimizing patient care and resource allocation.

Purpose of the Study:

  • To comprehensively evaluate diagnostic algorithms for myocardial infarction (MI) utilizing a high-sensitivity cardiac troponin I (hs-cTnI) assay.
  • To compare the safety and efficiency of various hs-cTnI-based and traditional diagnostic pathways.
  • To determine the optimal algorithm for early and accurate MI diagnosis in suspected cases.

Main Methods:

  • Prospective enrollment of 437 patients with suspected non-ST-segment elevation MI across nine Japanese emergency departments.
  • Evaluation of diagnostic algorithms including European Society of Cardiology (ESC) 0/1-h, ESC 0/2-h, High-STEACS, ADAPT, EDACS, HEART, and GRACE pathways.
  • Assessment of negative predictive value (NPV), sensitivity, and proportion of patients classified as low or high-risk for type 1 MI or cardiac death within 30 days.

Main Results:

  • All evaluated algorithms, except GRACE, successfully identified low-risk patients without missing primary outcomes.
  • hs-cTnI-based algorithms, particularly High-STEACS (68.5%), classified significantly more patients as low-risk compared to history/physical findings-based pathways (15-30%).
  • The High-STEACS pathway demonstrated higher efficiency by ruling out more patients (20.5%) at 0-hour hs-cTnI measurement compared to ESC algorithms (7.4%).

Conclusions:

  • hs-cTnI algorithms, especially the High-STEACS pathway, provide excellent safety for early myocardial infarction diagnosis.
  • These hs-cTnI-based strategies significantly enhance diagnostic efficiency in emergency settings.
  • The High-STEACS pathway represents a promising advancement for rapid and reliable MI rule-out.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
40
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
174
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
30